Autor: "Booth DR" - OpacWWW - Prolib Integro

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Booth DR"" wg kryterium: Autor

Wyświetlanie 1-6 z 6

Zaznacz stronę

Skocz do pozycji: 1.

Tytuł:: Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response.
Autorzy:: Read SA; Storr Liver Centre, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, Australia.
Tay ES; Storr Liver Centre, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, Australia.
Shahidi M; Storr Liver Centre, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, Australia.
O'Connor KS; Centre for Immunology and Allergy Research, University of Sydney at Westmead Hospital, Westmead, Australia.
Booth DR; Centre for Immunology and Allergy Research, University of Sydney at Westmead Hospital, Westmead, Australia.
George J; Storr Liver Centre, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, Australia.
Douglas MW; Storr Liver Centre, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, Australia; Centre for Infectious Diseases and Microbiology, Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney at Westmead Hospital, Westmead, Australia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Aug 27; Vol. 10 (8), pp. e0136227. Date of Electronic Publication: 2015 Aug 27 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Gene Expression Regulation, Enzymologic*
Hepacivirus/*metabolism
Hepatitis C, Chronic/*metabolism
Interferon-alpha/*metabolism
Liver/*metabolism
Proto-Oncogene Proteins/*biosynthesis
Receptor Protein-Tyrosine Kinases/*biosynthesis
Female ; Hep G2 Cells ; Hepacivirus/genetics ; Hepatitis C, Chronic/genetics ; Hepatitis C, Chronic/pathology ; Humans ; Interferon-alpha/genetics ; Interferons ; Interleukins/genetics ; Interleukins/metabolism ; Liver/pathology ; Male ; Proto-Oncogene Proteins/genetics ; Receptor Protein-Tyrosine Kinases/genetics ; Signal Transduction/genetics ; Suppressor of Cytokine Signaling 3 Protein ; Suppressor of Cytokine Signaling Proteins/genetics ; Suppressor of Cytokine Signaling Proteins/metabolism ; Axl Receptor Tyrosine Kinase

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: IL7Rα expression and upregulation by IFNβ in dendritic cell subsets is haplotype-dependent.
Autorzy:: McKay FC; Institute for Immunology and Allergy Research, Westmead Millennium Institute, Sydney, New South Whales, Australia ; Department of Medicine, University of Sydney, Sydney, New South Whales, Australia.
Hoe E
Parnell G
Gatt P
Schibeci SD
Stewart GJ
Booth DR; Pokaż więcej
Źródło:: PloS one [PLoS One] 2013 Oct 16; Vol. 8 (10), pp. e77508. Date of Electronic Publication: 2013 Oct 16 (Print Publication: 2013).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Haplotypes*
Dendritic Cells/*metabolism
Gene Expression Regulation/*drug effects
Interferon-beta/*pharmacology
Receptors, Interleukin-7/*genetics
Adult ; Aged ; Alternative Splicing ; Dendritic Cells/drug effects ; Dendritic Cells/immunology ; Female ; Heterozygote ; Homozygote ; Humans ; Lymphocyte Activation/immunology ; Male ; Middle Aged ; Monocytes/drug effects ; Monocytes/immunology ; Monocytes/metabolism ; Multiple Sclerosis/genetics ; Multiple Sclerosis/immunology ; Multiple Sclerosis/metabolism ; Myeloid Cells/immunology ; Myeloid Cells/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Receptors, Interleukin-7/metabolism ; Signal Transduction ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.
Autorzy:: Riveros C; Centre for Bioinformatics, Biomarker Discovery & Information-Based Medicine, University of Newcastle, and Hunter Medical Research Institute, Newcastle, Australia.
Mellor D
Gandhi KS
McKay FC
Cox MB
Berretta R
Vaezpour SY
Inostroza-Ponta M
Broadley SA
Heard RN
Vucic S
Stewart GJ
Williams DW
Scott RJ
Lechner-Scott J
Booth DR
Moscato P; Pokaż więcej
Corporate Authors:: ANZgene Multiple Sclerosis Genetics Consortium
Źródło:: PloS one [PLoS One] 2010 Dec 01; Vol. 5 (12), pp. e14176. Date of Electronic Publication: 2010 Dec 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Gene Expression Profiling*
Genome-Wide Association Study*
Multiple Sclerosis/*blood
RNA, Messenger/*metabolism
Transcription Factors/*metabolism
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/metabolism ; Oligodendroglia/cytology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosis.
Autorzy:: Field J; Florey Neuroscience Institutes, University of Melbourne, Melbourne, Victoria, Australia.
Browning SR
Johnson LJ
Danoy P
Varney MD
Tait BD
Gandhi KS
Charlesworth JC
Heard RN
Stewart GJ
Kilpatrick TJ
Foote SJ
Bahlo M
Butzkueven H
Wiley J
Booth DR
Taylor BV
Brown MA
Rubio JP
Stankovich J; Pokaż więcej
Corporate Authors:: Australia and New Zealand Multiple Sclerosis Genetics Consortium
Źródło:: PloS one [PLoS One] 2010 Oct 26; Vol. 5 (10), pp. e13454. Date of Electronic Publication: 2010 Oct 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Genetic Predisposition to Disease*
Polymorphism, Single Nucleotide*
HLA-DP Antigens/*genetics
Multiple Sclerosis/*genetics
Alleles ; Base Sequence ; Case-Control Studies ; Cohort Studies ; Gene Dosage ; HLA-DP beta-Chains

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood.
Autorzy:: Cox MB; Hunter Medical Research Institute, The University of Newcastle, Newcastle, New South Wales, Australia.
Cairns MJ
Gandhi KS
Carroll AP
Moscovis S
Stewart GJ
Broadley S
Scott RJ
Booth DR
Lechner-Scott J; Pokaż więcej
Corporate Authors:: ANZgene Multiple Sclerosis Genetics Consortium
Źródło:: PloS one [PLoS One] 2010 Aug 11; Vol. 5 (8), pp. e12132. Date of Electronic Publication: 2010 Aug 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Gene Expression Regulation*
Lymphocyte Activation/*genetics
MicroRNAs/*genetics
Multiple Sclerosis/*genetics
T-Lymphocytes/*immunology
T-Lymphocytes/*metabolism
Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Female ; Gene Regulatory Networks ; Humans ; Jurkat Cells ; Male ; Middle Aged ; Multiple Sclerosis/blood ; Multiple Sclerosis/immunology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis.
Autorzy:: Gandhi KS; Westmead Millennium Institute, University of Sydney, Sydney, Australia.
McKay FC
Diefenbach E
Crossett B
Schibeci SD
Heard RN
Stewart GJ
Booth DR
Arthur JW; Pokaż więcej
Źródło:: PloS one [PLoS One] 2010 May 05; Vol. 5 (5), pp. e10484. Date of Electronic Publication: 2010 May 05.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Electrophoresis, Gel, Two-Dimensional/*methods
Interferon-beta/*therapeutic use
Multiple Sclerosis/*blood
Multiple Sclerosis/*drug therapy
Adult ; Biomarkers/blood ; Chemokine CCL11/blood ; Demography ; Female ; Flow Cytometry ; Humans ; Interleukin-6/blood ; Male ; Middle Aged ; Sample Size ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Wyświetlanie 1-6 z 6

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies